CART-19 Cells For MRD Positive CD19+ ALL

Clinical trial NCT03027739 · UNKNOWN

Trial details

NCT number: NCT03027739
Sponsor: Fujian Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2016-11-01
Primary completion: 2019-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.